SIMARAVIBART
UNII 5C4T4W973X

Substance Identification & Data

This profile provides standardized clinical and technical data for Simaravibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5C4T4W973X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2657609-23-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5C4T4W973X

CAS Registry Number

2657609-23-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SIMARAVIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190326

National Cancer Institute reference terminology for clinical and research data.

INN ID

12423

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Simaravibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SIMARAVIBART

Common Names & Synonyms

GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-455) (VH (HOMO SAPIENS IGHV1-69*08 (95.9%) -(IGHD) -IGHJ4*01 (93.3%), CDR-IMGT (8.8.18) (26-33.51-58.97-114)) (1-125)-HOMO SAPIENS IGHG1*03, G1M3, NG1M1, G1V14-49 CH2 A1.3, A1.2, G114, G1V24 CH3 L107, S114 (CH1 R120 (222) (126-223), HINGE 1-15 (224-238), CH2 L1.3>A (242), L1.2>A (243), P114>G (337) (239-348), CH3 E12 (364), M14 (366), M107>L (436), N114>S (349-453), CHS (454-455)) (126-455)), (228-210')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-210') (V-KAPPA (HOMO SAPIENS IGKV3-11*01(97.8%)-IGKJ4*01 (100%), CDR-IMGT (6.3.5) (27-32.50-52.89-93)) (1'-103') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (149),V101 (187) (104'-210')); DIMER (234-234'':237-237'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

IMMUNOGLOBULIN G1 (242-ALANINE,243-ALANINE,337-GLYCINE,436-LEUCINE,442-SERINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL MAD0004J08 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MAD0004J08 .KAPPA.-CHAIN, DIMER

MAD 0004J08 [WHO-DD]

SIMARAVIBART (IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) PROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY)

SIMARAVIBART [INN]

Technical Codes

MAD-0004J08

External Clinical & Regulatory Resources

Previous UNII5C4T3X89ID

Next UNII5C4Y768228